Skip to content
healthcare.dev

Atovaquone

NDC 62135-528, Atovaquone, suspension, from Chartwell RX, LLC.

Product NDC
62135-528
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207833
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-528 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
62135-528-0962135052809210 mL in 1 BOTTLE (62135-528-09)
62135-528-24621350528242 TRAY in 1 BOX (62135-528-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-528-45)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/de0e29b5-a4c7-405c-a5b9-438729d9ba3a
  • NADAC price for package 62135052809

    GET /v1/drugs/nadac/62135052809

Use it

Look up 62135-528 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-528 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-528. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.